Alaunos Therapeutics (TCRT) Other Non-Current Assets (2009 - 2026)
Alaunos Therapeutics' Other Non-Current Assets was $776,000 in Q2 2026, down 22.2% from $997,000 a year earlier and down 6.6% from the prior quarter.
Powered by 
Analysis
Alaunos Therapeutics (TCRT) Other Non-Current Assets (2009 - 2026) Analysis & Trends
At the end of FY2025, Other Non-Current Assets at Alaunos Therapeutics came in at $887,000.
- Other Non-Current Assets shows a five-year compound annual growth rate of 3.6% (FY2020 to FY2025).
- In earlier years, Other Non-Current Assets was $500,000 in FY2022 (-20.8%) and $631,000 in FY2021 (-15.3%).
- The Q2 2026 figure marks the lowest quarterly Other Non-Current Assets since Q2 2023.
- The best year-over-year quarter for Other Non-Current Assets over five years was Q1 2022 (growth of 238.4%); the worst was Q3 2021 (a decline of 51.1%).
- Per Business Quant data, TCRT's Other Non-Current Assets in the three quarters before Q2 2026 was $831,000 (Q1 2026), $887,000 (Q4 2025) and $942,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 7.70 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 15.10 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 9.42 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 19.90 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 700.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 14.60 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 4.90 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 10.02 Bn |
| 10 | Alaunos Therapeutics | 4.16 Mn | 357,198.54 | - | 776,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 776,000.00 |
| Mar 31, 2026 | 831,000.00 |
| Dec 31, 2025 | 887,000.00 |
| Sep 30, 2025 | 942,000.00 |
| Jun 30, 2025 | 997,000.00 |
| Mar 31, 2025 | 1.05 Mn |
| Jun 30, 2023 | 501,000.00 |
| Mar 31, 2023 | 14.44 Mn |
| Dec 31, 2022 | 542,000.00 |
| Sep 30, 2022 | 14.44 Mn |
| Jun 30, 2022 | 542,000.00 |
| Mar 31, 2022 | 668,000.00 |
| Dec 31, 2021 | 673,000.00 |
| Sep 30, 2021 | 367,000.00 |
| Jun 30, 2021 | 381,000.00 |
| Mar 31, 2021 | 315,000.00 |
| Dec 31, 2020 | 875,000.00 |
| Sep 30, 2020 | 876,000.00 |
| Jun 30, 2020 | 874,000.00 |
| Mar 31, 2020 | 796,000.00 |
API Access
Alaunos Therapeutics Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=TCRT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "TCRT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=TCRT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();